This study investigates the management of invasive fungal infections (IFIs), including invasive mold infections (IMI). The purpose is to understand real-world patient characteristics and treatment patterns using mold-active triazoles (MATs). Invasive fungal infections are serious diseases caused by fungi that invade tissues, and mold-active triazoles are a type of antifungal medication used to treat them.
The study will look at how these medications are used in real-world settings and their effects on healthcare resources and patient outcomes. Participants will not receive any payment for taking part in this study.
- Who can participate: Adults who have started treatment with specific mold-active triazoles within the last 60 days can participate. Individuals currently in a research study for an investigational antifungal or those who have participated in this registry before are not eligible.
- Study details: Participants will be observed for their treatment patterns and healthcare usage. The study will not involve any experimental treatments. A placebo is not used in this study.

